Suzanne L. Topalian
Distinguished in Melanoma
Distinguished in Melanoma

Overview

Dr. Topalian is a physician-scientist whose studies of anti-tumor immunity have been foundational in developing cancer immunotherapy. She has published over 160 original research articles and reviews in this area and is one of the most highly cited researchers in the biomedical field. She received her medical and scientific training at Tufts University School of Medicine, Thomas Jefferson University Hospital, Children’s Hospital of Philadelphia and the National Cancer Institute. She joined the Johns Hopkins Kimmel Cancer Center in 2006 as the inaugural director of its Melanoma Program. Dr. Topalian is credited with advancing the clinical development of anti-PD-1 immunotherapy, and her work is widely recognized. She was named one of Nature’s 10 in 2014, and received the Karnofsky Award from ASCO in 2015, the Taubman Prize in 2016, the NCI’s Rosalind E. Franklin Award in 2018, the American Academy of Dermatology’s Gruber Memorial Cancer Research Award in 2020, and the Award for Distinguished Research in the Biomedical Sciences from the Association of American Medical Colleges in 2021 for landmark discoveries in cancer immunotherapy. Dr. Topalian was elected to the National Academy of Medicine in 2017, and to the American Association for Cancer Research Academy in 2022. Her work has opened new avenues of scientific investigation and established immunotherapy as a pillar of oncology.

Dr. Topalian is rated as a Distinguished provider by MediFind in the treatment of Melanoma. Her top areas of expertise are Merkel Cell Carcinoma, Melanoma, Neuroendocrine Tumor, and Anal Cancer.

Her clinical research consists of co-authoring 77 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 30 articles and participated in 1 clinical trial in the study of Melanoma.

Residency
Sidney Kimmel Medical College, General Surgery, 1985
Specialties
Surgical Oncology
Licenses
Surgery in MD
Fellowships
National Institutes of Health-NIH, Surgical Oncology, 1989
Languages Spoken
English
French
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
First Health
  • INSURANCE PLAN
  • MEDICARE PDP
  • PPO
Geisinger
  • HMO
  • POS
  • PPO

Locations

The Johns Hopkins Hospital
Baltimore, MD 21287

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


Similar Doctors
Julie R. Lange
Distinguished in Melanoma
Surgical Oncology
Distinguished in Melanoma
Surgical Oncology

Johns Hopkins Outpatient Center

601 North Caroline Street, Floor 8, Floor 8, 
Baltimore, MD 
 (1.2 miles away)
Languages Spoken:
English

Dr. Julie Lange is an assistant professor of surgery, dermatology and oncology at the Johns Hopkins University School of Medicine. Dr. Lange was one of the original members of the Johns Hopkins melanoma group when it was first formed in 1995 and now serves as a clinical co-director of the Melanoma Program. Dr. Lange introduced the sentinel node technique to Johns Hopkins for both melanoma and breast cancer in the 1990s and has extensive experience with this technique. Dr. Lange is a graduate of the Vanderbilt University School of Medicine and completed her general surgery training at Yale-New Haven Hospital. She completed a fellowship in surgical oncology and immunotherapy at the Surgery Branch of the National Cancer Institute as well. Dr. Lange joined the faculty of the Department of Surgery at Johns Hopkins in 1994 and subsequently earned a Sc.M. in clinical investigation at the Johns Hopkins Bloomberg School of Public Health. She has particular interest in melanoma at extremes of age, and in the factors associated with variance in melanoma care. Dr. Lange has published the largest study of melanoma in children, adolescents and young adults. She recognizes that melanoma in the older patient is a growing epidemic and has investigated the socioeconomic, demographic and healthcare factors that influence the treatment of melanoma in older persons. Dr. Lange is a member of the melanoma panel of the National Comprehensive Cancer Network, a group that annually evaluates and revises national treatment guidelines for melanoma. In 2015, she was inducted for her work into the Miller-Coulson Academy of Clinical Excellence, which recognizes outstanding clinicians at Johns Hopkins based on a number of factors, including communication and interpersonal skills, professionalism and humanism, a scholarly approach to clinical practice, and a passion for patient care. Dr. Lange is rated as a Distinguished provider by MediFind in the treatment of Melanoma. Her top areas of expertise are Melanoma, Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Lymphadenectomy.

Francesco M. Marincola
Distinguished in Melanoma
Surgical Oncology
Distinguished in Melanoma
Surgical Oncology
9000 Rockville Pike, 
Bethesda, MD 
 (34.0 miles away)
Languages Spoken:
English

Francesco Marincola is a Surgical Oncologist in Bethesda, Maryland. Dr. Marincola is rated as a Distinguished provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Breast Cancer, Colorectal Cancer, and Gliomatosis Cerebri.

Distinguished in Melanoma
General Surgery | Surgical Oncology
Distinguished in Melanoma
General Surgery | Surgical Oncology

Medstar Medical Group Ii LLC

1406 Crain S Hwy 106, 
Glen Burnie, MD 
 (10.5 miles away)
Languages Spoken:
English
Accepting New Patients

Edward Mccarron is a General Surgeon and a Surgical Oncologist in Glen Burnie, Maryland. Dr. Mccarron is rated as an Advanced provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Familial Pancreatic Cancer, Ogilvie Syndrome, Hernia Surgery, and Pancreatectomy. Dr. Mccarron is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Topalian's expertise for a condition
ConditionClose
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile